Related Experiment Video
Updated: Jul 14, 2026
05:17
Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
Myeloperoxidase: a target for new drug development?
E Malle1, P G Furtmüller, W Sattler
1Center of Molecular Medicine, Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria. ernst.malle@meduni-graz.at
British Journal of Pharmacology
|June 27, 2007
Summary
Myeloperoxidase (MPO) aids immunity but also causes tissue damage. Developing specific MPO inhibitors is crucial for treating inflammatory diseases while preserving host defense.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Myeloperoxidase (MPO) is key in innate immunity, producing antimicrobial oxidants.
- MPO utilizes chloride and hydrogen peroxide to generate hypochlorous acid (HOCl), a potent antimicrobial agent.
- MPO-derived oxidants are implicated in vascular inflammation and tissue damage.
Purpose of the Study:
- To explore the development of targeted Myeloperoxidase inhibitors.
- To discuss strategies for mitigating MPO-driven tissue damage.
- To review MPO's role in disease and potential therapeutic interventions.
Main Methods:
- Structural analysis of ferric MPO and its ligand complexes.
- Investigation of MPO reaction mechanisms and redox properties.
- Review of inhibitor development approaches, including mechanism-based and high-throughput screening.
Main Results:
- Detailed structural and mechanistic insights into MPO are available.
- Circulating MPO levels predict adverse cardiac events.
- MPO-derived chlorinated compounds serve as disease biomarkers.
Conclusions:
- Targeted MPO inhibition is a promising therapeutic strategy.
- Inhibitors should preserve MPO's host defense functions while blocking pathological activity.
- Physiologically relevant HOCl scavengers are also important therapeutic considerations.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:24Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
01:30Peroxisomes
Peroxisomes and mitochondria are two important oxygen-utilizing organelles in eukaryotic cells. Mitochondria carry out cellular respiration—the process that converts energy from food into ATP. Peroxisomes carry out a variety of functions, primarily breaking down different substances, such as fatty acids.The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within peroxisomes...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:27Protein Import into the Peroxisomes
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...